THE ERA OF
The field of neurology has been primed for a revolution in how new therapies are discovered. We have taken the charge to develop them.
At Praxis, we aim to reshape the human condition into a more freeing and fulfilled existence by treating complex neurological disorders.
The reason we come to work everyday is because of little men like this.
Collin — 4 years old. Suffers from Epilepsy
Praxis is a clinical-stage genetic neuroscience company that develops high-impact therapies for patients and families affected by complex and debilitating brain disorders
What is Praxis?
At Praxis we get things done. Praxis is the process of using a theory or something that you have learned in a practical way. It is a mindset that allows us to simplify the complex and independently define a solution without being restricted by predefined processes.
The field of neuroscience is at a pivotal stage in its evolution, much like the field of oncology was a decade ago. A confluence of scientific breakthroughs in the context of significant unmet need created conditions that poised that field for explosive advancement – not only in basic research and drug development – but in the transformation of patient care. In a short period of time the impact has been substantial, and the results have altered the course of humanity indefinitely.
The field of neuroscience is at the same nexus that cancer was then. Recognizing the underlying drivers of brain disorders, we are leading the union of genetics, neuroscience, psychiatry, and uniquely efficient clinical development in ways that allow us to unearth new therapies for patients living with brain disorders.
Like with most things in life, timing is critical. Fortunately, the time for genetic neuroscience is now and the future of treating debilitating neuropsychiatric disorders is incredibly bright.
CURRENT DEVELOPMENT PIPELINE
We are building a team of unrelenting scientists, clinicians, and leaders who have created a practical approach to drug discovery and development for complex brain disorders that will allow us to improve the course of neurologic research and care.
We are a values-driven organization focused on our people and centered around integrity, tenacity, intuition and experience.
[ September 17, 2020 ]
Praxis Precision Medicines Expands Leadership Team to Advance its Pipeline for CNS Disorders
[ July 28, 2020 ]
Praxis Precision Medicines Announces $110 Million Financing
[ June 11, 2020 ]
Praxis Precision Medicines Promotes Business Leader Stuart Chaffee to Chief Financial Officer
[ May 04, 2020 ]